Huber, M., Weber, R., Oppliger, R., Vernazza, P., Schmid, P., Schönbucher, P., et al. (2005). Interferon-alpha2a plus ribavirin 1000/1200 mg versus interferon-alpha2a plus ribavirin 600 mg for treatment of chronic hepatitis C among patients in opiate substitution programs : an open-label randomized multicenter trial : Korrekturexemplar. Infection, 33(1), 93–97.